RxDoctor Payments Data

Kristina Barber, MD

Physical Medicine & Rehabilitation · Parker, CONPI 1215499223

Payments from drug & device makers

What this record shows

21 manufacturers reported payments, led by Medtronic at 32.4% of the total. Among physical medicine & rehabilitation clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,891in general payments, 2019–2025

Across 119 payments — averaging $74.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Boston Scientific$3K
  • Abbott$1K
  • Nevro Corp.$438
  • Saluda Medical Americas, Inc.$348
  • AbbVie$329
  • plus $993 from 15 others

What the payments were for

  • Travel & lodging$4,08046%
  • Food & beverage$4,81154%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,891 in reported general payments places this provider in the 95th percentile of 199 physical medicine & rehabilitation providers in Colorado.

See all physical medicine & rehabilitation providers in Colorado

Medicare billing

Part B allowed, 2024
$38,409
Medicare patients
119
Services billed
331

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate29$18,100
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen70$3,098
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen68$2,791
Morphine Sulfate ErMorphine Sulfate40$1,050
Pregabalin44$988
Fentanyl11$972
Tramadol Hcl38$736
Oxycodone Hcl50$711
Naloxone Hcl12$691
Gabapentin50$669
Tizanidine Hcl15$322
Celecoxib15$301
Hydromorphone Hcl14$249
Morphine Sulfate11$160
Cyclobenzaprine Hcl12$147

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$39$18,10029 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 199 physical medicine & rehabilitation providers in Colorado.

Other physical medicine & rehabilitation in Parker

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →